BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 448162)

  • 1. Effect of dicarboxylic acids on lentigo maligna.
    Nazzaro-Porro M; Passi S; Balus L; Breathnach A; Martin B; Morpurgo G
    J Invest Dermatol; 1979 Jun; 72(6):296-305. PubMed ID: 448162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent progression of lentigo maligna to invasive melanoma during treatment with topical azelaic acid.
    McLean DI; Peter KK
    Br J Dermatol; 1986 Jun; 114(6):685-9. PubMed ID: 3718862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dicarboxylic acids on normal human melanocytes in dispersed tissue culture.
    Breathnach AS; Martin B; Nazzaro Porro M; Passi S; Mann P; Cooper J; Morpurgo G
    Br J Dermatol; 1979 Dec; 101(6):641-9. PubMed ID: 534609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten years' experience of treating lentigo maligna with topical azelaic acid.
    Nazzaro-Porro M; Passi S; Zina G; Breathnach AS
    Acta Derm Venereol Suppl (Stockh); 1989; 143():49-57. PubMed ID: 2773614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lentigo maligna with azelaic acid.
    Rodríguez Prieto MA; Manchado Lopez P; Ruiz Gonzalez I; Suarez D
    Int J Dermatol; 1993 May; 32(5):363-4. PubMed ID: 8505164
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%.
    Vereecken P; Heenen M
    Int J Clin Pract; 2002; 56(1):68-9. PubMed ID: 11831841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azelaic acid in lentigo maligna.
    Br J Dermatol; 1987 Apr; 116(4):605-7. PubMed ID: 3580294
    [No Abstract]   [Full Text] [Related]  

  • 8. Azelaic acid.
    Nazzaro-Porro M
    J Am Acad Dermatol; 1987 Dec; 17(6):1033-41. PubMed ID: 2963038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-microscopic investigations of pigment cells of lentigo maligna (melanosis circumscripta praeblastomatosa Dubreuilh) and lentigo maligna melanoma.
    Paul E; Illig L
    Arch Dermatol Res (1975); 1976 Aug; 256(2):179-87. PubMed ID: 962389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA synthesis of melanoma cells by azelaic acid.
    Leibl H; Stingl G; Pehamberger H; Korschan H; Konrad K; Wolff K
    J Invest Dermatol; 1985 Nov; 85(5):417-22. PubMed ID: 4056455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Black lesions of the skin.
    BECKER SW
    Calif Med; 1958 Mar; 88(3):228-33. PubMed ID: 13511215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of azelaic acid on cultures of lymphoma- and leukemia-derived cell lines, normal resting and stimulated lymphocytes and 3T3 fibroblasts.
    Picardo M; Passi S; Sirianni MC; Fiorilli M; Russo GD; Cortesi E; Barile G; Breathnach AS; Nazzaro-Porro M
    Biochem Pharmacol; 1985 May; 34(10):1653-8. PubMed ID: 4004885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
    Pathak MA; Ciganek ER; Wick M; Sober AJ; Farinelli WA; Fitzpatrick TB
    J Invest Dermatol; 1985 Sep; 85(3):222-8. PubMed ID: 4031538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathology of lentigo maligna Hutchinson. Melanosis circumscripta praecancerosa Dubreuilh (author's transl)].
    Tilgen W; Schnyder UW
    Virchows Arch A Pathol Anat Histol; 1974; 363(2):163-74. PubMed ID: 4849938
    [No Abstract]   [Full Text] [Related]  

  • 15. A possible mechanism of action for azelaic acid in the human epidermis.
    Schallreuter KU; Wood JW
    Arch Dermatol Res; 1990; 282(3):168-71. PubMed ID: 2114832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
    Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
    Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subungual lentigo maligna.
    Clouse WE; Sanders LJ
    Cutis; 1985 Aug; 36(2):153-5. PubMed ID: 4028830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
    Flotte TJ; Mihm MC
    Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dicarboxylic acids on normal and malignant melanocytes in culture.
    Hu F; Mah K; Teramura DJ
    Br J Dermatol; 1986 Jan; 114(1):17-26. PubMed ID: 3942687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.